Author

Junfei Wei

Baylor College of MedicineORCID 0000-0002-0041-5535Unclaimed ORCID profile · follow to get notified of new preprints

Biology Disciplines

Click to filter author papers

Signature Assays, Organisms & Methods

Click to filter · or open tag

Research Focus:drug response / drug discovery· 2 Approach:experimental assay· 2 Organism:mouse· 1 Assay:protein structure· 1 Organism:yeast· 1

Frequent Co-Authors

Bin ZhaniD· 2 shared Brian P. KeeganiD· 2 shared Cristina PovedaiD· 2 shared Jason T. KimataiD· 2 shared Jeroen B. K. PolletiD· 2 shared Jungsoon LeeiD· 2 shared Leroy VersteegiD· 2 shared María Elena BottazziiD· 2 shared

Activity by Year

2021-2022 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 45 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

2 shared papersMolecular Biology

Bin ZhanORCID

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

Receptor-binding domain recombinant protein on alum-CpG induces broad protection against SARS-CoV-2 variants of concern

Jeroen B. K. Pollet, Ulrich Strych, Wen‐Hsiang Chen, Leroy Versteeg, Brian P. Keegan, Bin Zhan, Junfei Wei, Zhuyun Liu, Jungsoon Lee, Rahki Kundu, Rakesh Adhikari, Cristina Poveda, María José Villar, Syamala Rani Thimmiraju, Brianna Lopez, , María Elena Bottazzi

This study evaluates a SARS-CoV-2 RBD subunit vaccine in mice, showing that adding CpG enhances immune response and neutralizing antibodies against multiple variants.

Vaccine · May 8, 2022Peer-reviewedMolecular Biology

Yeast-expressed Recombinant SARS-CoV-2 Receptor Binding Domain, RBD203-N1 as a COVID-19 Protein Vaccine Candidate

Wen‐Hsiang Chen, Jeroen B. K. Pollet, Ulrich Strych, Jungsoon Lee, Zhuyun Liu, Rakhi Tyagi Kundu, Leroy Versteeg, María José Villar, Rakesh Adhikari, Junfei Wei, Cristina Poveda, Brian P. Keegan, Aaron Oakley Bailey, Yilin Chen, Portia M. Gillespie, , María Elena Bottazzi

This paper describes the development of a recombinant SARS-CoV-2 RBD vaccine candidate produced in yeast, showing high purity, stability, and immunogenicity in mice.

Protein Expression and Purification · Oct 21, 2021Peer-reviewedMolecular Biology